Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques

• Gerard Zurawski ,

  * E-mail: gerardz@baylorhealth.edu

  Affiliations Vaccine Research Institute, Université Paris-Est, Faculté de Médecine, INSERM U955, and Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert- Chenevier, service d’immunologie clinique, INRIA SISTM, Créteil, France, Baylor Institute for Immunology Research and INSERM U955, Dallas, Texas, United States of America

  http://orcid.org/0000-0002-0168-3523

  ⨯
• Sandra Zurawski,

  Affiliations Vaccine Research Institute, Université Paris-Est, Faculté de Médecine, INSERM U955, and Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert- Chenevier, service d’immunologie clinique, INRIA SISTM, Créteil, France, Baylor Institute for Immunology Research and INSERM U955, Dallas, Texas, United States of America

  ⨯
• Anne-Laure Flamar,

  Current address: Weill Medical College of Cornell University, New York, New York, United States of America

  Affiliations Vaccine Research Institute, Université Paris-Est, Faculté de Médecine, INSERM U955, and Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert- Chenevier, service d’immunologie clinique, INRIA SISTM, Créteil, France, Baylor Institute for Immunology Research and INSERM U955, Dallas, Texas, United States of America

  ⨯
• Laura Richert,

  Affiliation INSERM U897, INRIA SISTM, Université Bordeaux Segalen, Bordeaux, France

  ⨯
• Ralf Wagner,

  Affiliation Molecular Microbiology and Gene Therapy Unit, Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany

  ⨯
• Georgia D. Tomaras,

  Affiliations Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America, Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• David C. Montefiori,

  Affiliations Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America, Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Mario Roederer,

  Affiliation Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America

  ⨯
• Guido Ferrari,

  Affiliation Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Christine Lacabaratz,

  Affiliation Vaccine Research Institute, Université Paris-Est, Faculté de Médecine, INSERM U955, and Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert- Chenevier, service d’immunologie clinique, INRIA SISTM, Créteil, France

  ⨯
• Henri Bonnabau,

  Affiliation INSERM U897, INRIA SISTM, Université Bordeaux Segalen, Bordeaux, France

  ⨯
• Peter Klucar,

  Affiliations Vaccine Research Institute, Université Paris-Est, Faculté de Médecine, INSERM U955, and Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert- Chenevier, service d’immunologie clinique, INRIA SISTM, Créteil, France, Baylor Institute for Immunology Research and INSERM U955, Dallas, Texas, United States of America

  ⨯
• Zhiqing Wang,

  Affiliations Vaccine Research Institute, Université Paris-Est, Faculté de Médecine, INSERM U955, and Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert- Chenevier, service d’immunologie clinique, INRIA SISTM, Créteil, France, Baylor Institute for Immunology Research and INSERM U955, Dallas, Texas, United States of America

  ⨯
• Kathryn E. Foulds,

  Affiliation Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America

  ⨯
• Shing-Fen Kao,

  Affiliation Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, United States of America

  ⨯
• Nicole L. Yates,

  Affiliation Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Celia LaBranche,

  Affiliation Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Bertram L. Jacobs,

  Affiliation School of Life Sciences, Center for Infectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona, United States of America

  ⨯
• Karen Kibler,

  Affiliation School of Life Sciences, Center for Infectious Diseases and Vaccinology, Arizona State University, Tempe, Arizona, United States of America

  ⨯
• Benedikt Asbach,

  Affiliation Molecular Microbiology and Gene Therapy Unit, Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany

  ⨯
• Alexander Kliche,

  Affiliation Molecular Microbiology and Gene Therapy Unit, Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany

  ⨯
• Andres Salazar,

  Affiliation Oncovir, Washington, D.C., United States of America

  ⨯
• Steve Reed,

  Affiliation Infectious Disease Research Institute, Seattle, Washington, United States of America

  ⨯
• Steve Self,

  Affiliation Vaccine and Infectious Disease and Public Health Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Raphael Gottardo,

  Affiliation Vaccine and Infectious Disease and Public Health Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Lindsey Galmin,

  Affiliation Advanced BioScience Laboratories, Inc., Rockville, Maryland, United States of America

  ⨯
• Deborah Weiss,

  Affiliation Advanced BioScience Laboratories, Inc., Rockville, Maryland, United States of America

  ⨯
• Anthony Cristillo,

  Affiliation Advanced BioScience Laboratories, Inc., Rockville, Maryland, United States of America

  ⨯
• Rodolphe Thiebaut,

  Affiliation INSERM U897, INRIA SISTM, Université Bordeaux Segalen, Bordeaux, France

  ⨯
• Giuseppe Pantaleo,

  Affiliation Centre Hospitalier Universitaire Vaudois, CH-101, Lausanne, Switzerland

  ⨯
•  [ ... ],
• Yves Levy

  Affiliation Vaccine Research Institute, Université Paris-Est, Faculté de Médecine, INSERM U955, and Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert- Chenevier, service d’immunologie clinique, INRIA SISTM, Créteil, France

  ⨯
• [ view all ]
• [ view less ]